Skip to content

Effect of devices (Low Power Laser and TENS) on Saliva Increase of Patients with Type II Diabetes Mellitus

Effect of Low Power Laser associated or not with the use of TENS in the Salivary Stimulation of patients with Type 2 Diabetes Melittus: randomized controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3tqv8r3
Enrollment
Unknown
Registered
2023-04-13
Start date
2022-04-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2

Interventions

8 participants will be selected for each group, in a total of 24 divided into three groups. Patients, research subjects, will be randomized into 3 different groups, according to the form of treatment
Group 2 (G2) – Salivary stimulation through electrical stimulation
Group 3 (G3) - Association of both therapies: low power laser + electrical stimulation. After screening, patients will receive random numbers distributed by computer program. In sequence, eight number
E02.594.540
E02.331.800

Sponsors

Universidade de Brasília
Lead Sponsor
Empresa Brasileira de serviços Hospitalares - EBSERH
Collaborator

Eligibility

Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participate in the Extension UnB Project Periodontal Treatment in Diabetic Patients; having type 2 Diabetes Mellitus;present unstimulated salivary flow value less than or equal to 0.2 ml/min, and stimulated less than or equal to 0.7 ml/min; have controlled periodontal disease; Be between 30 and 65 years old

Exclusion criteria

Exclusion criteria: Presence of severe systemic complications and comorbidities;patients who do not have their glycated hemoglobin levels tested;smokers;transplanted;positive history for epilepsy;patients using electronic devices such as: pacemaker, insulin pump and brain drain;difficulty in motor coordination;presence of systemic conditions that may influence the physiology of the salivary gland, such as: Sjogren's syndrome, hypothyroidism, history of radiotherapy in the head and neck regions and chemotherapy treatment that preceded 3 months

Design outcomes

Primary

MeasureTime frame
It is expected that the treatment of salivary stimulation with electrical methods, in association or not with the devices, provides an increase in salivary flow, at rest and stimulated, in type 2 diabetic patients

Secondary

MeasureTime frame
It is estimated that the increase in flow provides an improvement in the quality of life of patients in order to reduce complaints of hyposalivation and xerostomia

Countries

Brazil

Contacts

Public ContactFernanda Nunes

Universidade de Brasília

dra.fernandadepaula@gmail.com+5561981148001

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 3, 2026